Oncimmune Holdings plc (LON: ONC), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, and its partner, Genostics Company Limited,

Oncimmune Holdings plc (LON: ONC), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announced that it has signed

Oncimmune Holdings plc (LON: ONC), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announces the appointment of Dr.

Oncimmune Holdings plc (LON: ONC), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announced its distributor in Columbia,

Oncimmune Holdings plc (LON: ONC), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announces that its Spanish distributor,

Dr Adam M Hill, CEO of Oncimmune said: “The acquisition of Protagen will accelerate Oncimmune’s product discovery process, will grow our library of known and novel immunogenic proteins, and will

Cancer symptoms are not always obvious and can sometimes go undetected, so it’s important to be unaware of any unexplained changes to your body. If you notice your voice sounding

Lung cancer is one of the most common and deadly types of cancer, according to the NHS. Most cases of the disease are caused by smoking, although you can still develop lung

A cough that seems to be getting worse could be one of the earliest, and most common, signs of lung cancer. The cough may be getting progressively more painful, or

In the fight against cancer, there is a surprising tool in the arsenal: the food we eat. That is because some nutrients in food have been found to play a